Q-linea AB

44
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0011527845
SEK
24.36
-0.54 (-2.15%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Q-linea AB Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-216.00
-229.00
-268.00
-231.00
-218.00
-177.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
16.00
-18.00
2.00
-29.00
-28.00
0.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-182.00
-228.00
-250.00
-249.00
-237.00
-169.00
Cash Flow from Investing Activities
-5.00
-7.00
315.00
-23.00
-32.00
-159.00
Cash Flow from Financing Activities
131.00
245.00
-6.00
278.00
253.00
1.00
Net Cash Inflow / Outflow
-56.00
9.00
57.00
4.00
-15.00
-328.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in SEK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Q-linea AB
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Profit Before Tax
-216.871
-360.751
144.00
39.88%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
16.112
-1.969
17.00
918.28%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-182.495
46.58
-228.00
-491.79%
Cash Flow from Investing Activities
-5.043
-85.899
80.00
94.13%
Cash Flow from Financing Activities
131.273
24.411
107.00
437.76%
Net Cash Inflow / Outflow
-56.231
-14.629
-42.00
-284.38%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.034
0.279
0.00
-87.81%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 20.14% vs 8.91% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-182.50
-228.52
20.14%